Search Results - Feng Bi

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors

    Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors by Wenke Li, Menghui Xu, Mo Cheng, Jing Wei, Lin Zhu, Yu Deng, Fukun Guo, Feng Bi, Ming Liu

    Published 2025-07-01

    ABSTRACT Background Immunotherapy combined with chemotherapy has become the standard treatment for HER2‐negative gastric cancer (GC), but its clinical benefits remain limited, with a median progression‐free survival (mPFS) of 6–8 months and median overall survival (mOS) of 15–18 months. These outcom...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: